Method for decreasing body weight using a somatostatin...

Details Method for decreasing body weight using a somatostatin... Method for decreasing body weight using a somatostatin...

2005-11-29

2010-02-16

Kosar, Andrew D (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07662784

ABSTRACT:
The present invention relates to a method of decreasing body weight in a patient. The method includes the step of administering a therapeutically effective amount of a somatostatin or a somatostatin agonist to said patient. A pharmaceutical/cosmetic composition comprises the somatostatin or somatostatin agonist. Such products are used to prepare such compositions for the reduction or body weight in a human or mammalian animal.

REFERENCES:
patent: 4133782 (1979-01-01), Vale et al.
patent: 4146612 (1979-03-01), Veber
patent: 4190575 (1980-02-01), Sarantakis
patent: 4190648 (1980-02-01), Veber
patent: 4209426 (1980-06-01), Sarantakis
patent: 4211693 (1980-07-01), Rivier et al.
patent: 4215039 (1980-07-01), Sarantakis
patent: 4224199 (1980-09-01), Meyers et al.
patent: 4235886 (1980-11-01), Freidinger et al.
patent: 4238481 (1980-12-01), Rink et al.
patent: 4261885 (1981-04-01), Sakakibara et al.
patent: 4282143 (1981-08-01), Sarantakis
patent: 4291022 (1981-09-01), Sandrin et al.
patent: 4310518 (1982-01-01), Freidinger et al.
patent: 4316890 (1982-02-01), Kamber et al.
patent: 4328214 (1982-05-01), Rink et al.
patent: 4358439 (1982-11-01), Sieber et al.
patent: 4360516 (1982-11-01), Freidinger et al.
patent: 4369179 (1983-01-01), Rink et al.
patent: 4395403 (1983-07-01), Bauer et al.
patent: 4435385 (1984-03-01), Bauer et al.
patent: 4485101 (1984-11-01), Coy et al.
patent: 4486415 (1984-12-01), Freidinger
patent: 4522813 (1985-06-01), Nutt
patent: 4585755 (1986-04-01), Morgan et al.
patent: 4603120 (1986-07-01), Kamber
patent: 4650787 (1987-03-01), Schally et al.
patent: 4684620 (1987-08-01), Hruby et al.
patent: 4725577 (1988-02-01), Schally et al.
patent: 4728638 (1988-03-01), Bauer et al.
patent: 4853371 (1989-08-01), Coy et al.
patent: 4871717 (1989-10-01), Coy et al.
patent: 4904642 (1990-02-01), Coy et al.
patent: 5506339 (1996-04-01), Coy et al.
patent: 5583104 (1996-12-01), LaRusso
patent: 5708135 (1998-01-01), Coy et al.
patent: 5763200 (1998-06-01), Dunmore et al.
patent: 0 083 305 (1983-07-01), None
patent: 0 030 920 (1984-02-01), None
patent: 0 203 031 (1986-11-01), None
patent: 0 329 295 (1989-08-01), None
patent: 0 363 589 (1990-04-01), None
patent: 0 389 180 (1990-09-01), None
patent: 0 505 680 (1992-09-01), None
patent: 0 395 417 (1995-02-01), None
patent: 0657174 (1995-06-01), None
patent: 2 522 655 (1983-09-01), None
patent: 2 095 261 (1982-09-01), None
patent: 88/02756 (1988-04-01), None
patent: 88/05052 (1988-07-01), None
patent: 90/12811 (1990-11-01), None
patent: 91/09056 (1991-06-01), None
patent: WO 91/18016 (1991-11-01), None
patent: WO9635950 (1996-11-01), None
patent: WO 97/01579 (1997-01-01), None
patent: WO9711962 (1997-04-01), None
patent: WO9809991 (1998-03-01), None
patent: WO9810786 (1998-03-01), None
Martinez et al. (1996) European Journal of Pharmacology, vol. 296, p. 153-160.
Porzano et al. (1993) Diabetes Res., vol. 22, p. 3-10.
J. Rudinger. In: Peptide Hormones, JA Parsons, Ed. (1976) 1-7.
Lloyd et al.: American Physiological Society, vol. 268, pp. G102-G106, 1995.
Carretta, R. et al., “Reduction of Blood Pressure in Obese Hyperinsulinaemic Hypertensive Patients During Somatostatin Infusion”, Journal of Hypertension, 7(6):S196-S197 (1989).
Clark, J. A. et al., “Multiple Regions of Ligand Discrimination Revealed by Analysis of Chimeric Parathyroid Hormone 2 (PTH2) and PTH/PTH-Related Peptide (PTHrP) Receptors”, Molecular Endocrinology, 12(2):193-206 (1998).
Horvath, A. et al., “Conformations of somatostatin analogues having antitumor activity,” Peptides, 1992, Proceedings of the 22ndEuropean Peptide Symposium, Sep. 13-19, 1992 Interlaken, Switzerland, p. 533-534.
Huang, H.-J. et al., “ Hyperamylinemia, Hyperinsulinemia, and Insulin Resistance in Genetically Obese LA/N-cpRats”, Supplement to Hypertension, 19(1):I-101-1109 (1992).
Lunetta, M. et al., “Long-Term Octreotide Treatment Reduced Hyperinsulinemia, Excess Body Weight and Skin Lesions in Severe Obesity With Acanthosis Nigricans”, J. Endocrinol. Invest., 19:699-703 (1996).
Van Binst, G. et al., “Backbone Modifications in Somatostatin Analogues: Relation Between Conformation and Activity”, Peptide Research, 5(1):8-13 (1992).
Zamboni, M. et al., “Obesity and Regional Body-Fat Distribution in Men: Separate and Joint Relationships to Glucose Tolerance and Plasma Lipoproteins”,Am J Clin. Nutrition, 60:682-687 (1994).
Shimon, I., et al., “Somatostatin receptor subtype specificity in human fetal pituitary cultures,” 1997, J. Clin. Invest., 89:789-798.

Affiliated with

Also associated with

Rating

Method for decreasing body weight using a somatostatin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for decreasing body weight using a somatostatin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for decreasing body weight using a somatostatin... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4167891